Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
about
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Comparison of biosimilar filgr ...... atients with multiple myeloma.
@en
type
label
Comparison of biosimilar filgr ...... atients with multiple myeloma.
@en
prefLabel
Comparison of biosimilar filgr ...... atients with multiple myeloma.
@en
P2093
P2860
P356
P1433
P1476
Comparison of biosimilar filgr ...... atients with multiple myeloma.
@en
P2093
Anita Schmitt
Anthony D Ho
Jens Hillengass
Katharina Lisenko
Marc-Andrea Baertsch
Mark Kriegsmann
Mathias Witzens-Harig
Patrick Wuchter
Petra Pavel
Renate Meiser
P2860
P356
10.1111/TRF.14211
P577
2017-06-26T00:00:00Z